Be the first to like this.
2 comment(s). Last comment by ahbah 2021-06-25 13:23
Posted by ahbah > 2021-06-25 13:23 | Report Abuse
Indonesia’s now in the middle of its most severe wave of the COVID-19 pandemic.
Now thanks in part to a wealthy entrepreneur presently serving as the Minister for State Owned Enterprises (SOE), the country’s national drug regulator authorized the use of ivermectin on an off-label basis targeting COVID-19.
In 2020, the Indonesian government brought in a wealthy, dynamic, and aggressive businessman to shake up and turn around state-owned enterprises known as “SOE.” Now they’ve turned Erick Thohir loose on COVID-19, and there’s nothing but business.
A pragmatic yet big thinker, the new SOE Minister of the Food and Drug Supervisory Agency, known for the acronym BPOM, issued a distribution permit for ivermectin, meaning the regulatory body for this Southeast Asian nation of 270 million, the worlds’ fourth most populous nation, has authorized the use of the generic, low-cost drug as a therapeutic for COVID-19.
Based on the results of a study, this BPOM action led to a distribution license to PT Indofarma Tbk; and production now has commenced with plans for distribution of over 4 million units per month. This fascinating and unfolding situation is the result of the dynamic SOE minister driving state enterprises to solve the COVID-19 crisis as the BPOM still takes the position that the treatment is accepted but on an off-label basis.
But BPOM has declared formally that ivermectin is now authorized as a therapy for COVID-19.
No result.
1
2
Koon Yew Yin's Blog
3
4
Koon Yew Yin's Blog
6
save malaysia!
7
Good Articles to Share
Boeing Embarrassed as ‘Stuck’ Astronauts to Return with SpaceX
8
Good Articles to Share
Telegram chief Pavel Durov to appear in court after French arrest
#
Stock
Score
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock
Time
Signal
Duration
Stock
Time
Signal
Duration
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
MuttsInvestor
865 posts
Posted by MuttsInvestor > 2021-06-25 13:17 | Report Abuse
"" A study by researchers from the University of Texas together with Pfizer and BioNtech and published this month by Nature journal found that antibodies elicited by the vaccine were still able to neutralize all tested variants, including Delta, albeit at reduced strength."""
In another Words....... Reduced Efficacy.
HEADLINE is TOTALLY MISLEADING !!! ( As expected from PFIZER !! )